Oo

China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut

Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its firs
China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论